Dan Cirucci: Pennacchio To NJ: Unshackle Docs, Release HCQ

Monday, April 6, 2020

Pennacchio To NJ: Unshackle Docs, Release HCQ

As evidence continues to mount supporting the effectiveness of hydroxychloroquine (HCQ) against the coronavirus, New Jersey remains behind the curve in its approach to treatment and prevention of COVID-19.

Sen. Pennacchio is calling on the State health department to launch a study comparing coronavirus rates in patients who have been prescribed HCQ for other diseases and people who have not taken the drug. (SenateNJ.com)

Numerous doctors have joined New Jersey State Senator Joe Pennacchio in his call to unshackle them, and allow doctors to treat patients and prescribe HCQ as both a treatment and early preventative against this virus.

“Minimally, the State should have secured HCQ pills and developed a distribution protocol,” said Senator Pennacchio.

Adding to that request, the Senator challenged the State Department of Health to immediately perform a “retrospective study” of people who have routinely taken HCQ as a drug therapy for other diseases such as lupus and rheumatoid arthritis. Such a study comparing this population of patients to an equal number of patients who have not been treated with HCQ would prove to be an early treatment protection against COVID-19.

Others such as Dr. Philip DeFina, PhD, a research scientist and former associate professor at New York University School of Medicine, agree with Senator Pennacchio.

“A retrospective analysis of people who are already taking HCQ as part of an ongoing treatment plan for ailments such as auto-immune disorders would be extremely informative data to assess whether or not these same people appear to have a decreased likelihood of contracting COVID-19. Additionally, some first responders, military personnel and front-line healthcare workers who are already taking lower, prophylactic doses of HCQ would be an excellent source population for a scientifically valid retrospective study. Furthermore, doctor’s nationwide have been prescribing HCQ for compassionate use in patients who have tested positive for COVID-19. There has been some reporting that these outcomes are being tracked for potential studies, and they absolutely should be.”

“Relying on federal ‘guidance’ which seems to have their own issues about accepting HCQ is not enough. The State of New Jersey must immediately take a proactive approach,” concluded Senator Pennacchio.

No comments:

Post a Comment

About Dan Cirucci

He has been cited by Rush Limbaugh, quoted in the New York Times, featured at Real Clear Politics and Lucianne.com and interviewed on radio, TV and in social media.

He's Dan Cirucci, the founder and editor-in chief of the Dan Cirucci Blog, Matt Rooney's sidekick on Save Jersey's videocasts and one of the most widely honored public relations professionals in his field. He's also been a public relations consultant to numerous organizations and individuals and hosted The Advocates on RVN-TV.

Inducted into the Philadelphia Public Relations Hall of Fame, for many years he served as a Lecturer in Corporate Communication at Penn State University. A former President of the Philadelphia Public Relations Association (PPRA) he has lectured at Rowan University, Temple University, The College of New Jersey and Arcadia University. He has conducted workshops on public relations for thousands of participants throughout the nation and has taught countless others the art of public speaking. He has also advised numerous lawyers, judges, public officials and political candidates.

Cirucci is a prolific writer and his op-ed pieces have appeared in the Philadelphia Daily News, Philadelphia Inquirer, Courier-Post and other publications.

A native of Camden NJ, Cirucci is a former President of the Philadelphia chapter of the International Association of Business Communicators. Cirucci served as Associate Executive Director of the Philadelphia Bar Association for nearly 30 years. He served as Chair of Penn State University's Professional Advisory Board for the Corporate Communication major at Penn State Abington and on the Pennsylvania Bar Association's Judicial Selection Commission.

He received his MA degree from Rowan University and his BA from Villanova University. He has been named a Distinguished Alumnus of Rowan's public relations program and received the E. A. "Wally" Richter Leadership Award, the highest honor from the National Association of Bar Executives' Communications Section. He has also been honored by numerous other local, state and national groups.

In his hometown of Camden, Cirucci taught fifth grade at the Ulysses Wiggins Elementary School named for the founder of the Camden NAACP. There he was one of the first teachers in the country to teach African-American history to inner city students. He later served as editor of a local weekly newspaper, as Assistant to the Township Manager of Cherry Hill Township and as Associate Director of Communications at the New Jersey State Bar Association.

Cirucci's passions include politics, the popular culture, books and authors, art, communication, music, theatre, movies, dining and travel.

Attributions & Terms Of Use

Unless explicitly attributed to others, the opinions and views expressed on this blog are my own, and do not represent the views of any employer or other organization.

By using this blog, you agree that all original content on this blog is copyright of Daniel A. Cirucci. You may quote from my posts provided that you clearly identify me as the author, link to the original post or home address of this blog, and do not charge for access to the website, publication or other media in which the quote appears.

I like to link to people who link to me.

Although comments are moderated, I accept no responsibility for what other people say, and I reserve the right to block or remove any comment for any reason or no reason.

Any e-mails sent to me are subject to publication, and any disputes regarding this site will be litigated exclusively in the jurisidiction in which I reside at the time of the dispute.

About Lijit Ads
We now have Lijit Ads on our web site. Please note that Lijit's Privacy Policy can be found here. Lijit collects only anonymous information unless a reader chooses to submit personal information to Lijit. Lijit permits readers to opt out of the collection of this anonymous site visit data by clicking here.